Updated Jul 16, 2026
Bartushak Jaime is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Jaime Bartushak is the Chief Financial Officer of Citius Pharmaceuticals, Inc. and Citius Oncology, Inc., where he plays a key role in managing the financial operations of the companies focused on oncology therapies. He has been involved in multiple SEC filings related to these companies.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-22 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 825.0K | $0.00 | |
| 2025-12-01 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 825.0K | $0.00 | |
| 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 825.0K | $0.00 |
Jaime Bartushak is the Chief Financial Officer of Citius Pharmaceuticals, Inc. and Citius Oncology, Inc., where he plays a key role in managing the financial operations of the companies focused on oncology therapies. He has been involved in multiple SEC filings related to these companies.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bartushak Jaime profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.